Trump Administration Axes £200m HIV Vaccine Programme, Sparking Outrage.
In a shocking move, the Trump administration has abruptly terminated a £200 million HIV vaccine research programme, dealing a severe blow to global efforts to combat the virus. The decision, announced on Friday by officials from the National Institutes of Health’s (NIH) HIV division, has left scientists and health experts reeling.
The programme, led by researchers at Duke University and the Scripps Research Institute, was a cornerstone of HIV vaccine development. Collaborating with a network of global research partners, the teams were not only advancing the quest for an HIV vaccine but also contributing to treatments for a range of conditions, including Covid-19 therapies, snake antivenom, and autoimmune disease treatments.
A senior NIH official, speaking anonymously as they were not authorised to comment publicly, confirmed the decision, stating, “The consortia for HIV/AIDS vaccine development and immunology was reviewed by NIH leadership, which does not support it moving forward.” The official added that the NIH plans to redirect its focus towards “currently available approaches to eliminate HIV/AIDS.”
This cancellation is the latest in a string of cuts to HIV-related initiatives under the Trump administration, particularly those aimed at prevention. In a separate move, the NIH has also paused funding for a clinical trial of an HIV vaccine developed by Moderna, further raising concerns about the future of HIV research.
The decision has sparked widespread criticism, with fears it could set back progress on a vaccine that has eluded scientists for decades. Experts warn that the loss of this programme, with its far-reaching implications for global health, could have devastating consequences for millions affected by HIV/AIDS and other diseases.
As the scientific community grapples with this setback, calls are growing for the decision to be reconsidered, with many urging the administration to prioritise long-term investment in life-saving research.
